samedan logo
 
 
 
spacer
home > pmps > summer 2003 > changing times for process automation in the pharmaceutical sector
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Changing Times for Process Automation in the Pharmaceutical Sector

For once the professional fortune tellers are in agreement - pharmaceuticals look set to provide a rare opportunity for significant growth in an otherwise difficult market for process automation suppliers over the coming years. This article will attempt to explain the reasons for this and looks at some of the latest technology available for use throughout the pharmaceutical industry.

According to a recent report from US-based pundits at the ARC Advisory Group, the global pharmaceutical and food and drink industries will provide the biggest growth opportunities for automation suppliers until at least 2006. The growth in the total automation market limped along at less than one per cent in 2000-2001 and ARC expects this to reach an average of just 3.4 per cent a year through to 2006. Larry O'Brien, ARC's Director of Research for the process industries, says: "In this environment of limited growth, the food and beverage and pharmaceutical industries will offer the strongest potential opportunity in the long term."


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Roger Trew, European Development Advisor for the International Society for Pharmaceutical Engineering (ISPE)

Roger Trew is European Development Advisor for the International Society for Pharmaceutical Engineering (ISPE). He is writing on behalf of TOTAL Processing and Packaging, a new event which combines Interphex, Eurochem, Pakex and the PPMA Machinery Only show. The show will focus on all elements relevant to the processing and packaging value chain and will take place at Birmingham NEC, UK, from 29th March to 1st April 2004.

spacer
Roger Trew
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Hansa Biopharma initiate a new Contract Development and Manufacturing project in immunological diseases

Vilnius, Lithuania, and Lund, Sweden - December 20th, 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced a new service agreement to develop the next generation of IgG cleaving enzymes.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement